Followed by a maintenance phase of 2 to 4 mg per week for an additional 2 to 4 weeks
In educational frameworks, DSIP is positioned at most for the patient with documented, persistent sleep-architecture problems who has genuinely failed sleep hygiene, CBT-I, and melatonin, and who explicitly understands they would be engaging with something investigational rather than a validated treatment
Most medical professionals will recommend alternate injection sites to avoid scarring and irritation
The FDA and FTC one-two punch should dent sales, but as the stem cell wild west has proven, that may not stop sales
The FDA has classified BPC-157 in Category 2 for bulk drug substances, citing possible safety issues in compounding, such as immunogenicity, impurities, and insufficient safety evidence for suggested administration routes
Additional preclinical themes include angiogenesis (through endothelial cell migration and tube formation), modulation of inflammatory signalling, and reported effects on cardiac, dermal and neural tissue in animal models